4. DAMAGE CONTROL
RESUSCITATION
Aims:
Stop the bleeding
Treat the coagulopathy
Prevent further coagulopathy
Minimise tissue damage
DCR
Haemosta
tic
resuscitat
ion
Permissive
Hypotensi
on
Damage
control
surgery
5. DAMAGE CONTROL
RESUSCITATION
Aims:
Stop the bleeding
Treat the coagulopathy
Prevent further coagulopathy
Minimise tissue damage
DCR
Haemosta
tic
resuscitat
ion
Permissive
Hypotensi
on
Damage
control
surgery
= 1:1 empiric
transfusion
6. PREDICTION OF BLEEDING
Low EXTEM CA5 predicts
bleeding1
NPV for massive
transfusion = 0.99
Standard care:
Uses clinical acumen or
MHP tools to detect
bleeding: specificity = 70-
80%
EXTEM CA5 values
1. Davenport et al, 2011, JTH
2. Cantle PM, Cotton BA. Prediction of massive transfusion in trauma. Crit Care Clin
2017;33:71-84.
3. Schroll R, Swift D, Tatum D, et al. Accuracy of shock index versus ABC score to predict
EXTEM CA5 values
7. PREDICTION OF BLEEDING
Low EXTEM CA5 predicts
bleeding1
NPV for massive
transfusion = 0.99
Standard care:
Uses clinical acumen or
MHP tools to detect
bleeding: specificity = 70-
80%
EXTEM CA5 values
1. Davenport et al, 2011, JTH
2. Cantle PM, Cotton BA. Prediction of massive transfusion in trauma. Crit Care Clin
2017;33:71-84.
3. Schroll R, Swift D, Tatum D, et al. Accuracy of shock index versus ABC score to predict
EXTEM CA5 values
8. DOES DCR DO WHAT IT SAYS ON
THE TIN?
Coagulopathy progresses with transfusion
9. DOES DCR DO WHAT IT SAYS ON
THE TIN?
Coagulopathy progresses with transfusion
13. VHA GUIDED TRANSFUSION
TREATMENTReference Study Type No TEG or
ROTEM
Treatment Algorithm Outcomes
Johansson
2009
Retrospective
cohort, historical
control
442
390
TEG ↑R - FFP
α<52 – FFP or Fg
MA<46 – plts
Ly30>8% - TA
DCR + TEG improved
survival by 11%
Kashuk
2011
Prospective
Historical control
34
34
r-TEG G < 5.0 and:
↑R > 110sec - FFP
α <66 – cryo
MA <54 - plts
Mortality fell from 65 % to
29%
Schochl
2010
Retrospective 131 ROTEM FgC: if FIBTEM MCF
<10mm
PCC: if EXTEM CT
>1.5x ULN
Signif. reduction in mortality
compared to expected
mortality (p=0.03)
Schochl
2011
Retrospective
2 databases
80
601
ROTEM As above
Nil
Reduction of blood
exposure
No difference in death
14. REVERSAL OF TRAUMA-INDUCED COAGULOPATHY USING
FIRST-LINE COAGULATION FACTOR CONCENTRATES OR
FRESH FROZEN PLASMA (RETIC): A SINGLE-CENTRE,
PARALLEL-GROUP, OPEN-LABEL, RANDOMISED TRIAL.
100 patients
Randomised to factor concentrate therapy vs FFP
Inclusion: trauma haemorrhage, coagulopathic on ROTEM
Intervention: guided by ROTEM
Secondary endpoint: ROTEM guided therapy = clinical reduction in
bleeding
Innerhofer et al, Lancet Haematology, 2017
15. Overall mortality rate 27.9%
Deaths: 20 in CCA group 11 in VHA
group (p = 0.049)
Median time to death:
11.5 vs 3.5 hrs (VHA vs CCA)
Significant difference in death in
first 6 hours
Gonzalez et al. 2016 Annals of Surgery
N = 111
Rapid TEG vs CCA
Primary endpoint = 28 day
mortality
16. ITACTIC TRIAL
Large European RCT in 6 major trauma centres
392 patients
Primary endpoint: proportion of subjects alive
and free from MT at 24h
Powered to see a 13% reduction in primary
outcome in VHA group
Closed Dec 2018
Coagulopathy = poor outcomes
So treat coagulopathy
Clinical judgement alone = 65%
Start with:
Injury and hypoperfusion – more coagulopathy
Increase in thrombin generation – coagulation cascade activated by ? TF, and talk about effects on prot c and effects on factor assays
Effects on glycocalyx
Platelet recruitment – talk about platelet changes in trauma haem
Fibrinogen levels
fibrinolysis